Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Stebbins

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)C Watzl, C C Stebbins, E O Long
European Journal of Immunology|August 1, 1990
Human natural killer cells and mature T lymphocytes express identical CD3 zeta subunits as defined by cDNA cloning and sequence analysisP Moingeon, C C Stebbins, L D'Adamio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II moleculesC C Stebbins, M E Peterson, W M Suh, et al.
The Journal of Experimental Medicine|January 1, 1995
The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependentC C Stebbins, G E Loss, C G Elias, et al.
Molecular and Cellular Biology|September 13, 2000
Natural killer cells and mast cells from gp49B null mutant mice are functionalS Rojo, C C Stebbins, M E Peterson, et al.
Cellular Immunology|July 1, 1990
Characterization of functional GTP binding proteins in Jurkat T cell mutants lacking either CD3-Ti or CD2 surface receptorsP Moingeon, Y J Jin, C C Stebbins, et al.
European Journal of Immunology|March 1, 1991
Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activationP E Moingeon, J L Lucich, C C Stebbins, et al.
Immunological Reviews|August 22, 2001
Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)E O Long, D F Barber, D N Burshtyn, et al.
Neurology|May 11, 2012
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MSS E Bushnell, Z Zhao, C C Stebbins, et al.
Immunity|April 16, 1999
Essential role of LAT in T cell developmentW Zhang, C L Sommers, D N Burshtyn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)C Watzl, C C Stebbins, E O Long
European Journal of Immunology|August 1, 1990
Human natural killer cells and mature T lymphocytes express identical CD3 zeta subunits as defined by cDNA cloning and sequence analysisP Moingeon, C C Stebbins, L D'Adamio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II moleculesC C Stebbins, M E Peterson, W M Suh, et al.
The Journal of Experimental Medicine|January 1, 1995
The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependentC C Stebbins, G E Loss, C G Elias, et al.
Molecular and Cellular Biology|September 13, 2000
Natural killer cells and mast cells from gp49B null mutant mice are functionalS Rojo, C C Stebbins, M E Peterson, et al.
Cellular Immunology|July 1, 1990
Characterization of functional GTP binding proteins in Jurkat T cell mutants lacking either CD3-Ti or CD2 surface receptorsP Moingeon, Y J Jin, C C Stebbins, et al.
European Journal of Immunology|March 1, 1991
Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activationP E Moingeon, J L Lucich, C C Stebbins, et al.
Immunological Reviews|August 22, 2001
Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)E O Long, D F Barber, D N Burshtyn, et al.
Neurology|May 11, 2012
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MSS E Bushnell, Z Zhao, C C Stebbins, et al.
Immunity|April 16, 1999
Essential role of LAT in T cell developmentW Zhang, C L Sommers, D N Burshtyn, et al.
Pageof 1